mecamylamine has been researched along with Inadequate Sleep in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirotsu, C | 1 |
| Pedroni, MN | 1 |
| Berro, LF | 1 |
| Tufik, S | 1 |
| Andersen, ML | 1 |
1 other study available for mecamylamine and Inadequate Sleep
| Article | Year |
|---|---|
Nicotine and sleep deprivation: impact on pain sensitivity and immune modulation in rats.
Topics: Animals; Hyperalgesia; Immunity; Interleukin-4; Interleukin-6; Male; Mecamylamine; Nicotine; Pain; P | 2018 |